Literature DB >> 606971

[Short and long-term results after external Dacryocystorhinostomy by Kaleff-Hollwich's method (author's transl)].

H Busse, A Promesberger, H Promesberger.   

Abstract

By means of a short and long-term study the recanalising effect of Kaleff-Hollwich's (1977) Dacryocystorhinostomy was determined and compared with Ohm's (1921) and Dupuy-Dutemps (1921) methods. With both procedures a high percentage (75-85) of permanent patency of the tear ducts is obtained. With Kaleff-Hollwich's method a practically continuous mucosa anastomosis can be formed. Stenosis by insufficiency of the canaliculi can be avoided in the opinion of the authors by exact refixing of the medial palpebral ligament. Information in the literature of patency in over 90 percent of cases is revealed after critical evaluation in the great majority of such reports as post-operative ability to rinse the tear ducts in one direction and give no indication of the end result.

Entities:  

Mesh:

Year:  1977        PMID: 606971

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  4 in total

1.  [Long term patency rate of the external dacryocystorhinostomy. A retrospective study in the years 1991-2000 at the University Eye Hospital in Halle].

Authors:  D Horix; H G Struck
Journal:  Ophthalmologe       Date:  2004-03       Impact factor: 1.059

Review 2.  [Current status of dacryocystorhinostomy].

Authors:  H-W Meyer-Rüsenberg; S Vujancevic; K-H Emmerich
Journal:  Ophthalmologe       Date:  2009-03       Impact factor: 1.059

Review 3.  [Microendoscopic tear duct surgery].

Authors:  K-H Emmerich; R Ungerechts; H-W Meyer-Rüsenberg
Journal:  Ophthalmologe       Date:  2009-03       Impact factor: 1.059

4.  [The Interdisciplinary Conference on Lacrimal System Disorders of ophthalmic and ENT surgeons at the University Hospital Halle : An analysis of present patient material].

Authors:  H-G Struck; A Glien; M Herzog; A Sandner; S K Plontke; J Heichel
Journal:  HNO       Date:  2016-06       Impact factor: 1.284

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.